Bryan Hubbard, CEO of Americans for Ibogaine and former Kentucky opioid policy leader, shares his extraordinary journey from Appalachian poverty to spearheading a historic $50 million Texas initiative to bring ibogaine therapy through FDA approval. After witnessing the opioid epidemic devastate his community and discovering the limitations of current addiction treatments, Bryan fought through political setbacks and state-to-state rejections to build a multi-state movement for this potentially breakthrough therapy. This conversation explores ibogaine's promise for treating opioid dependency and PTSD, the resistance from established recovery systems, and why innovation in addiction treatment could offer hope to those at "the end of hope."
Podden och tillhörande omslagsbild på den här sidan tillhör
iHeartPodcasts. Innehållet i podden är skapat av iHeartPodcasts och inte av,
eller tillsammans med, Poddtoppen.